{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T10:28:39Z","timestamp":1775039319817,"version":"3.50.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology Nursing"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.soncn.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T15:16:57Z","timestamp":1491405417000},"page":"208-218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Next Generation Sequencing and Multi-Gene Panel Testing: Implications for the Oncology Nurse"],"prefix":"10.1016","volume":"33","author":[{"given":"Patricia A.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.soncn.2017.02.007_bib0010","author":"National Library of Medicine"},{"key":"10.1016\/j.soncn.2017.02.007_bib0015","series-title":"Cancer Genetics Overview (PDQ)-Health Professional Version Overview","author":"PDQ Cancer Genetics Editorial Board","year":"2017"},{"key":"10.1016\/j.soncn.2017.02.007_bib0020","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1188\/13.ONF.437-439","article-title":"Next generation sequencing: implications for oncology care","volume":"40","author":"Mahon","year":"2013","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.soncn.2017.02.007_bib0025","author":"DNA Learning Center"},{"key":"10.1016\/j.soncn.2017.02.007_bib0030","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.AOG.0000443280.91145.4f","article-title":"Technology assessment in obstetrics and gynecology: Genetics and molecular diagnostic testing","volume":"123","author":"American College of Obstetricians and Gynecologists","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0035","author":"Lynce"},{"key":"10.1016\/j.soncn.2017.02.007_bib0040","doi-asserted-by":"crossref","DOI":"10.1172\/JCI78507","article-title":"Pioneering geneticist Mary-Claire King receives the 2014 Lasker-Koshland special achievement award in medical science","author":"Hurst","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.soncn.2017.02.007_bib0045","author":"National Cancer Institute"},{"key":"10.1016\/j.soncn.2017.02.007_bib0050","series-title":"PDQ Genetics of Breast and Gynecologic Cancers","author":"PDQ Cancer Genetics Editorial Board","year":"2016"},{"key":"10.1016\/j.soncn.2017.02.007_bib0055","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2017.02.007_bib0060","author":"US Preventive Services Taskforce"},{"key":"10.1016\/j.soncn.2017.02.007_bib0065","author":"Centers for Disease Control and Prevention"},{"key":"10.1016\/j.soncn.2017.02.007_bib0070","author":"National Comprehensive Cancer Network (NCCN)"},{"key":"10.1016\/j.soncn.2017.02.007_bib0075","author":"Nelson"},{"key":"10.1016\/j.soncn.2017.02.007_bib0080","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/cncr.29010","article-title":"Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel","volume":"121","author":"Tung","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2017.02.007_bib0090","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1200\/JCO.2015.65.5522","article-title":"Panel testing is not a panacea","volume":"34","author":"Axilbund","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0095","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamaoncol.2015.2690","article-title":"Clinical actionability of multigene panel testing for hereditary breast and ovarian cancer risk assessment","volume":"7","author":"Desmond","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/jso.21856","article-title":"Translational advances regarding hereditary breast cancer syndromes","volume":"105","author":"Gage","year":"2012","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0105","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1586\/14737140.2015.1090879","article-title":"Genetic risk assessment and prevention: the role of genetic testing panels in breast cancer","volume":"15","author":"Lerner-Ellis","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.soncn.2017.02.007_bib0110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.soncn.2015.02.007","article-title":"Genetic tests to identify risk for breast cancer","volume":"31","author":"Lynch","year":"2015","journal-title":"Semin Oncol Nurs"},{"key":"10.1016\/j.soncn.2017.02.007_bib0115","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamaoncol.2015.2699","article-title":"Usefulness of multigene testing catching the train that's left the station","volume":"1","author":"Swisher","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s10897-014-9695-6","article-title":"Cancer risk assessment using genetic panel testing: considerations for clinical application","volume":"23","author":"Hiraki","year":"2014","journal-title":"J Genet Counsel"},{"key":"10.1016\/j.soncn.2017.02.007_bib0125","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1001\/jama.2015.8088","article-title":"Treatment decision making and genetic testing for breast cancer: mainstreaming mutation","volume":"314","author":"Katz","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2017.02.007_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-013-0371-z","article-title":"Next-generation sequencing for inherited breast cancer risk: counseling through the complexity","volume":"16","author":"Rainville","year":"2014","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.soncn.2017.02.007_bib0135","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1188\/16.ONF.114-117","article-title":"Management of individuals with a mutation in the ataxia telangiectasia mutated gene","volume":"43","author":"Mahon","year":"2016","journal-title":"Oncol Nurs Forum"},{"key":"10.1016\/j.soncn.2017.02.007_bib0140","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1200\/JCO.2015.63.7454","article-title":"Panel testing for familial breast cancer: calibrating the tension between research and clinical care","volume":"34","author":"Thompson","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0145","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1200\/JCO.2015.65.0747","article-title":"Frequency of germline mutations in 25 cancer susceptibility genes in a sequential series of patients with breast cancer","volume":"34","author":"Tung","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0150","series-title":"Spectrum of mutations identified in a 25-gene hereditary cancer panel for patients with breast cancer","author":"Sharma","year":"2015"},{"key":"10.1016\/j.soncn.2017.02.007_bib0155","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1001\/jama.297.23.2587","article-title":"Limited family structure and BRCA gene mutation status in single cases of breast cancer","volume":"297","author":"Weitzel","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.soncn.2017.02.007_bib0160","series-title":"GeneReviews\u00ae [Internet]","article-title":"Ataxia-Telangiectasia","author":"Gatti","year":"1999"},{"key":"10.1016\/j.soncn.2017.02.007_bib0165","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1038\/sj.onc.1209873","article-title":"ATM and breast cancer susceptibility","volume":"25","author":"Ahmed","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.soncn.2017.02.007_bib0170","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1200\/JCO.2013.53.6607","article-title":"Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk evaluation","volume":"32","author":"Kurian","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0175","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/humu.21604","article-title":"Variants in activators and downstream targets of ATM, radiation exposure and contralateral breast cancer risk in the WECARE Study","volume":"33","author":"Brooks","year":"2012","journal-title":"Hum Mutat"},{"key":"10.1016\/j.soncn.2017.02.007_bib0180","series-title":"UpToDate","article-title":"Overview of hereditary breast and ovarian syndromes","author":"Peshkin","year":"2016"},{"key":"10.1016\/j.soncn.2017.02.007_bib0185","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/gim.2013.160","article-title":"The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience","volume":"16","author":"Maurer","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/j.soncn.2017.02.007_bib0190","author":"PDQ Cancer Genetics editorial board"},{"key":"10.1016\/j.soncn.2017.02.007_bib0195","author":"National Comprehensive Cancer Network (NCCN)"},{"key":"10.1016\/j.soncn.2017.02.007_bib0200","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1002\/1097-0142(19940201)73:3<643::AID-CNCR2820730323>3.0.CO;2-5","article-title":"Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction","volume":"73","author":"Claus","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.soncn.2017.02.007_bib0205","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.nurpra.2016.07.027","article-title":"Breast cancer risk assessment: calculating lifetime risk using the Tyrer-Cuzick Model","volume":"12","author":"Himes","year":"2016","journal-title":"J Nurse Prac"},{"key":"10.1016\/j.soncn.2017.02.007_bib0210","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/sim.1668","article-title":"A breast cancer prediction model incorporating familial and personal risk factors","volume":"23","author":"Tyrer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.soncn.2017.02.007_bib0215","first-page":"75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soncn.2017.02.007_bib0220","series-title":"Essentials of Genetic and Genomic Nursing: Competencies, Curricula Guidelines, and Outcome Indicators","first-page":"2009","author":"Consensus Panel on Genetic\/Genomic Nursing Competencies","year":"2009"},{"key":"10.1016\/j.soncn.2017.02.007_bib0225","series-title":"Essential genetic and genomic competencies for nurses with graduate degrees","author":"Greco","year":"2012"},{"key":"10.1016\/j.soncn.2017.02.007_bib0230","first-page":"397","article-title":"Multigene panel testing for hereditary cancer risk","volume":"7","author":"Grissom","year":"2016","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ajog.2015.03.003","article-title":"Hereditary breast cancer: an update on risk assessment and genetic testing in 2015","volume":"213","author":"Stuckey","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.soncn.2017.02.007_bib0240","series-title":"Scope and Standards of Practice: Genetics\/Genomics Nursing","author":"International Society of Nurses in Genetics","year":"2016"},{"key":"10.1016\/j.soncn.2017.02.007_bib0245","author":"American Nurses Credentialing Center (ANCC)"},{"key":"10.1016\/j.soncn.2017.02.007_bib0250","author":"National Cancer Institute"},{"key":"10.1016\/j.soncn.2017.02.007_bib0255","author":"National Society of Genetic Counselors"},{"key":"10.1016\/j.soncn.2017.02.007_bib0260","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/gim.2014.147","article-title":"A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment","volume":"17","author":"Hampel","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.soncn.2017.02.007_bib0265","series-title":"Genetics Home Reference","author":"National Library of Medicine (US)","year":"2016"},{"key":"10.1016\/j.soncn.2017.02.007_bib0270","author":"McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University"},{"key":"10.1016\/j.soncn.2017.02.007_bib0275","series-title":"GeneReviews [Internet]","year":"1993"},{"key":"10.1016\/j.soncn.2017.02.007_bib0280","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.ejca.2013.04.028","article-title":"Contralateral breast cancer after radiotherapy among BRCA and BRCA2 mutation carriers: a WECARE report","volume":"49","author":"Bernstein","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.soncn.2017.02.007_bib0285","author":"National Cancer Institute"}],"container-title":["Seminars in Oncology Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208117300177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749208117300177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:31:51Z","timestamp":1760081511000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749208117300177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0749208117300177"],"URL":"https:\/\/doi.org\/10.1016\/j.soncn.2017.02.007","relation":{},"ISSN":["0749-2081"],"issn-type":[{"value":"0749-2081","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next Generation Sequencing and Multi-Gene Panel Testing: Implications for the Oncology Nurse","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology Nursing","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soncn.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}